Abstract
This chapter explores the potential for new biotechnologically-enabled weapons to compete with nuclear weapons as far as effect on strategic stability, and assesses whether the assumptions in traditional strategic stability models are still valid when applied to such scenarios, and how changing capabilities and adversaries may shape approaches to arms control, verification, and monitoring. When thinking about biotechnology from a security perspective, anticipating the types of security threats that may emerge as science and technology advance, the potential consequences of those threats, the probability that adversaries will obtain or pursue them, adversarial intent, and potential effect on strategic stability is necessary. The range and spectrum of possible capabilities and actors are expanding. The most recent addition to the genome-editing arsenal is CRISPR, a bacteria-derived system that is among the simplest genome-editing tools. The CRISPR-Cas9 system—and emerging variants on the system—enables unprecedented control and ease when editing the genome. With parallels to remote ‘command and control’ of the genome, this is one aspect that makes the technology different from earlier gene-editing methods. Contemporary analyses of emerging technologies often expose tenuous links or disconnections between technical realities and mainstream scholarship. How, when, where, and in what form the shifting nature of technological progress may bring enhanced or entirely new capabilities, many of which are no longer the exclusive domain of a single nation-state, is contested and requires better analytical tools to enable assessment and inform policy choices. This work is hardly the only one to consider the biosecurity implications of CRISPR, gene-editing, and broader issues of biotechnology. As far as is known, it is the only one to address these emerging life sciences technologies in the context of nuclear strategic stability and implications for balance of power, arms control, and international security.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
“New scientific and technological developments relevant to the Convention: Some examples,” BWC Preparatory Committee, Eighth Review Conference of the States Parties to the Convention on the Prohibition of the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on Their Destruction, BWC/CONF.VIII/PC/WP.18, August 5, 2016.
- 2.
- 3.
For an excellent overview of the CRISPR-Cas9 system by two of the discovers, see [31].
References
Rennstich KJ (2008) The making of a digital world: the evolution of technological change and how it shaped our world. Palgrave MacMillan, New York
Unclassified Key Judgments of the National Intelligence Estimate (2007) Prospects for Iraq’s Stability: a Challenging Road Ahead. Office of the Director of National Intelligence, https://www.dni.gov/files/documents/Newsroom/Press%20Releases/2007%20Press%20Releases/20070202_release.pdf
Biotechnology Research in an Age of Terrorism. National Academies Press, Washington, D.C. (2004)
Globalization, Biosecurity, and the Future of the Life Sciences. National Academies Press, Washington, D.C. (2006)
Bill Gates warns tens of millions could be killed by bio-terrorism. The Guardian (UK), 18 Feb 2017. https://www.theguardian.com/technology/2017/feb/18/bill-gates-warns-tens-of-millions-could-be-killed-by-bio-terrorism
Clapper JR (2016) Worldwide Threat Assessment of the US Intelligence Community, Statement for the Record to the Senate Armed Services Committee, 9 Feb 2016. https://www.dni.gov/files/documents/SASC_Unclassified_2016_ATA_SFR_FINAL.pdf
Letter to the President, President’s Council of Advisors on Science and Technology, Executive Office of the President, Nov 2016. https://obamawhitehouse.archives.gov/sites/default/files/microsites/ostp/PCAST/pcast_biodefense_letter_report_final.pdf
Reeves RG et al (2018) Agricultural research, or a new bioweapon system? Science 362(6410):35–37
Dando M (2016) Find the time to discuss new bioweapons. Nature 535:9. https://www.nature.com/news/find-the-time-to-discuss-new-bioweapons-1.20206
Vogel KM, Ouagrham-Gormley SB (2018) Anticipating emerging biotechnology threats: a case study of CRISPR. Polit Life Sci 37(2):203–219
Gronvall G (2018) The security implications of synthetic biology. Survival 60(4):165–180
Oye KA et al (2014) Regulating gene drives. Science 345(6197):626–628
Koblentz GD (2004) Pathogens as weapons: the international security implications of biological warfare. Int Secur 29(1):84–122
Peterson S (2002) Epidemic disease and national security. Secur Stud 12(2):43–81
Elbe S (2002) HIV/AIDS and the changing landscape of war in Africa. Int Secur 27(2):159–177
McInnes C, Lee Kelley (2006) Health, security and foreign policy. Rev Int Stud 32:5–23
Letendre K, Fincher CL, Thornhill R (2010) Does infectious disease cause global variation in the frequency of intrastate armed conflict and civil war? Biol Rev 85(3):669–683
Waddington C (2014) Ebola outbreak in Guinea: a different type of regional stability threat. Africa Confl Monthly Monit 2014(5):47–51
Heymann DL et al (2015) Global health security: the wider lessons from the west African Ebola virus disease epidemic. Lancet 385(9980):1805–1806
Omoleke SA, Mohammed I, Saidu Y (2016) Ebola viral disease in West Africa: a threat to global health, economy and political stability. J Public Health Africa 7(1):27–40
Kalra S et al (2014) The emergence of Ebola as a global health security threat: from ‘Lessons Learned’ to coordinated multilateral containment efforts. J Glob Infect Dis 6(4): 164–177
Jackson RJ et al (2001) Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J Virol 75:1205–1210
Chen N et al (2011) Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: pathogenesis, prophylaxis, and antiviral therapy. Virology 409(2):328–337
MacKenzie D (2003) US develops lethal new viruses. New Sci. https://www.newscientist.com/article/dn4318-us-develops-lethal-new-viruses/
Guerra FM et al (2017) The basic reproduction number (R0) of measles: a systematic review. Lancet 17(12):e420–e428
Fine PE (1993) Herd immunity: history, theory, practice. Epid Rev 15:265–302
Wallinga J, Lévy-Bruhl D, Gay NJ, Wachmann CH (2001) Estimation of measles reproduction ratios and prospects for elimination of measles by vaccination in some western European countries. Epid Infect 127:281–295
Porteus M (2006) Mammalian gene targeting with designed zinc finger nucleases. Mol Ther 13:438–446
Mansilla-Soto J, Riviere I, Boulad F et al (2016) Cell and gene therapy for the beta-thalassemias: advances and prospects. Hum Gene Ther 27(4): 295–304
Jo Yi, Kim H, Ramakrishna S (2015) Recent developments and clinical studies utilizing engineered zinc finger nuclease technology. Cell Mol Life Sci 72(20):3819–3830
Doudna JA, Charpentier E (2014) The new frontier of genome engineering with CRISPR-Cas9. Science 346(6213):1077–1088
Ran FA et al (2015) In vivo genome editing using Staphylococcus aureus Cas9. Nature 520:186–191
Zetsche B et al (2015) Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-cas system. Cell 163(3):759–771
Fonfara I et al (2016) The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Nature 532:517–521
McKenna A et al (2016) Whole organism lineage tracing by combinatorial and cumulative genome editing. Science 353(6298):aaf7907-11
Yoshimi K, Kaneko T, Voigt B, Mashimo T (2014) Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR-cas platform. Nat Commun 5(4240):1–9
Heo TY et al (2015) CRISPR/Cas9 nuclease-mediated gene knock-in in bovine-induced pluripotent cells. Stem Cells Dev 24:393–402
Han H et al (2014) One-step generation of myostatin gene knockout sheep via the CRISPR/Cas9 system. Front Agric Sci Eng 1: 2–15
Kang Q et al (2014) Improving pig genetic resistance and muscle production through molecular biology. In: Proceeding of 10th world congress genetics applied livestock production. https://asas.org/docs/default-source/wcgalp-proceedings-oral/362_paper_10607_manuscript_1526_0.pdf?sfvrsn=2
Efficient genome editing of genes involved in neural crest development using the CRISPR/Cas9 system in Xenopus embryos. Cell Biosci 6(22) (2016). http://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-016-0088-4
Liang P et al (2015) CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell 6(5):363–372
Cyranoski D, Reardon S (2015) Embryo editing sparks epic debate. Nature 520:593–595
Normile D (2018) Shock greets claim of CRISPR-edited babies. Science 362(6418):978–979
He J (2019) China condemns ‘baby gene editing’ scientist. BBC News, 21 Jan 2019. https://www.bbc.com/news/world-asia-46943593
Wang H, Yang H (2019) Gene-edited babies: what went wrong and what could go wrong. PLOS Biol. https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3000224
O’Green H, Abigail S, Sega DJ (2015) How specific is CRISPR/Cas9 really?. Curr Opin Chem Biol 29:72–78
Tsai SQ et al (2015) GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol 33:187–197
Chapman JE, Gillum D, Kiani S (2017) Approaches to reduce CRISPR off-target effects for safer genome editing. Appl Biosaf J ABSA Int 22(1):7–13
Cyranoski D (2019) China set to introduce gene-editing regulation following CRISPR-baby furore. Nature. https://www.nature.com/articles/d41586-019-01580-1
Wei X, Nielsen R (2019) CCR52-∆32 is deleterious in the homozygous state in humans. Nat Med 25:909–910
Zhou M et al (2016) CCR5 is a suppressor for cortical plasticity and hippocampal learning and memory. eLife 20(5):e20985
Joy MT et al (2019) CCR54 is a therapeutic target for recovery after stroke and traumatic brain injury. Cell 176(5):1143–1157
Regalado A (2019) China’s CRISPR twins might have had their brains inadvertently enhanced. MIT Technol Rev. https://www.technologyreview.com/s/612997/the-crispr-twins-had-their-brains-altered/
Cyranoski D (2019) Russian biologist plans more CRISPR-edited babies. Nature. https://www.nature.com/articles/d41586-019-01770-x
Martin S (2002) The role of biological weapons in international politics: the real military revolution. J Strateg Stud 25(1):76
Nuclear Posture Review Report (2010) viii, United States Department of Defense. https://dod.defense.gov/Portals/1/features/defenseReviews/NPR/2010_Nuclear_Posture_Review_Report.pdf
Nuclear Posture Review Executive Summary (2018) United States Department of Defense. https://media.defense.gov/2018/Feb/02/2001872877/-1/-1/1/EXECUTIVE-SUMMARY.PDF
Kosal ME (2018) WMD strategy gap: capacities, capabilities, and collaboration. PRISM 7(3):50–67
Smithson Amy E (1999) Tall order: crafting a meaningful verification protocol for the biological weapons convention. Polit Life Sci 18(1):79–85
Littlewood J (2005) The biological weapons convention: a failed revolution. Ashgate Publishing, Aldershot
Littlewood J (2012) The biological weapons convention. In: Faure G (ed) Unfinished business: why international negotiations fail. University of Georgia Press, Athens, pp 107–129
Sims NA (2006) Toward the BWC review conference: diplomacy still in the doldrums. Disarmament Diplomacy, vol 82. http://www.acronym.org.uk/old/dd/dd82/82ns.htm
Hart J, Trapp R (2012) Science, technology, and the biological weapons convention. Arms Control Today 42(8):15–21
Araki M, Ishii T (2014) International regulatory landscape and integration of corrective genome editing into in vitro fertilization. Reprod Biol Endocrinol 12(108). http://www.rbej.com/content/12/1/108
Tebas P et al (2014) Gene editing of CCR68 in autologous CD4 T cells of persons infected with HIV. N Engl J Med 370:901–910
Flotte TR (2015) Therapeutic germ line alteration: has CRISPR/Cas9 technology forced the question? Hum Gene Ther 26(5):245–246
NIH-RAC. NIH Guidelines for research involving recombinant or synthetic nucleic acid molecules (NIH Guidelines), Apr 2016. http://osp.od.nih.gov/office-biotechnology-activities/biosafety/nih-guidelines
World at Risk: The Report of the Commission on the Prevention of WMD Proliferation and Terrorism, Dec 2008. https://www.absa.org/leg/WorldAtRisk.pdf
Kosal ME (2009) Nanotechnology for chemical and biological defense. Springer Academic Publishers, New York
Ostfield M (2009) Pathogen security: the illusion of security in foreign policy and biodefense. Int J Risk Assess Manag 12:204–221
Kosal ME (2008) U.S. policies to reduce the threat of chemical terrorism, in 9/11 + 6 Initiative Foreign Policy Priorities for a Secure America, The Partnership for a Secure America, May 2008. http://www.psaonline.org/downloads/CHEMICAL%20report%208-28-08.pdf
Truman HS (1949) Inaugural address. Online by Gerhard Peters and John T. Woolley, The American Presidency Project, 20 Jan 1949. http://www.presidency.ucsb.edu/ws/?pid=13282
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kosal, M.E. (2020). Emerging Life Sciences: New Challenges to Strategic Stability. In: Kosal, M. (eds) Disruptive and Game Changing Technologies in Modern Warfare. Advanced Sciences and Technologies for Security Applications. Springer, Cham. https://doi.org/10.1007/978-3-030-28342-1_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-28342-1_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-28341-4
Online ISBN: 978-3-030-28342-1
eBook Packages: Political Science and International StudiesPolitical Science and International Studies (R0)